| Caroline Wogon, CCC-SLP | |
|
1988 Haire Rd, Fort Mill, SC 29715-8807 | |
| (803) 548-9113 | |
| (803) 548-9116 |
| Full Name | Caroline Wogon |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1988 Haire Rd, Fort Mill, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265043624 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 6882 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Caroline Wogon, CCC-SLP 1598 Worthington Xing, Rock Hill, SC 29732-7773 Ph: (803) 517-4780 | Caroline Wogon, CCC-SLP 1988 Haire Rd, Fort Mill, SC 29715-8807 Ph: (803) 548-9113 |
News Archive
New research finds breastfeeding doesn't appear to protect against multiple sclerosis (MS) relapses, despite previous studies suggesting there may be a protective role. The research is published in the July 6, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.
In Europe alone, more than 25,000 people die each year from infections caused by multi-resistant bacteria. Researchers from University of Copenhagen have now developed and characterized a substance that quickly and effectively kills the virulent bacteria. The substance employs a multifunctional mechanism that reduces the risk of antibiotic resistance. The findings have recently been published in the scientific journal Chemistry & Biology.
A new JDRF-funded study shows that many of the genes known to play a role in type 1 diabetes (T1D) are expressed in pancreatic beta cells, suggesting that the cell responsible for producing insulin may be playing a part in its own destruction to lead to T1D.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, announced that it is has successfully completed a Phase 1 single ascending dose (SAD) clinical study with Z944, its novel, oral, T-type calcium channel blocker.
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).
› Verified 1 days ago
Terri Hennessey, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1599 Farm House Dr, Fort Mill, SC 29715 Phone: 803-835-0176 Fax: 803-835-0151 | |
Mrs. Teresa Ann Rimmer, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2233 Deerfield Dr, Fort Mill, SC 29715 Phone: 803-548-2527 | |
Ms. Lindsey Noelle Scrogin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1988 Haire Rd Ste 101, Fort Mill, SC 29715 Phone: 803-322-7491 | |
Melissa Maxwell, MS.ED, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1503 Josie Ln Apt 405, Fort Mill, SC 29708 Phone: 978-685-6321 | |
Jamilia Bush, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1698 Highway 160 W Ste 240, Fort Mill, SC 29708 Phone: 704-654-8599 | |
Shannon Weynand, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 870 Gold Hill Rd Ste 104, Fort Mill, SC 29708 Phone: 803-620-8250 Fax: 803-638-6901 | |
Mrs. Sarah Komornik Smith, MSP CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2222 Sunset Cir, Fort Mill, SC 29715 Phone: 803-622-7939 Fax: 803-548-6200 |